(ASAN) Asana - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US04342Y1047
Stock: Work, Management, Software, Platform, Tasks
Total Rating 22
Risk 29
Buy Signal -1.46
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 63.5% |
| Relative Tail Risk | -11.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.22 |
| Alpha | -84.37 |
| Character TTM | |
|---|---|
| Beta | 1.717 |
| Beta Downside | 1.128 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.26% |
| CAGR/Max DD | -0.22 |
Description: ASAN Asana January 11, 2026
Asana, Inc. (NYSE:ASAN) provides a cloud-based work-management platform that enables individuals, team leads, and executives to coordinate daily tasks, cross-functional projects, and strategic initiatives across a broad set of industries worldwide.
The company employs a hybrid go-to-market strategy that blends product-led growth (self-service sign-ups), a direct sales force, and channel partners, allowing it to serve customers in technology, retail, education, non-profit, government, healthcare, hospitality, media, manufacturing, professional services, and financial services.
Key recent metrics: FY 2024 revenue reached **$815 million**, a **23 % year-over-year increase**, driven by a **38 % YoY growth in annual recurring revenue (ARR)**; net dollar retention stood at **118 %**, indicating strong upsell and low churn. The broader SaaS market is benefitting from sustained remote-work adoption and corporate spending on productivity tools, with the global work-management software TAM projected to exceed **$30 billion** by 2027.
For a deeper quantitative view, consult the ValueRay dashboard for ASAN’s valuation and risk metrics.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -219.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 11.44 > 1.0 |
| NWC/Revenue: 21.52% < 20% (prev 26.65%; Δ -5.13% < -1%) |
| CFO/TA 0.09 > 3% & CFO 78.6m > Net Income -219.1m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (237.8m) vs 12m ago 3.56% < -2% |
| Gross Margin: 89.48% > 18% (prev 0.89%; Δ 8859 % > 0.5%) |
| Asset Turnover: 90.23% > 50% (prev 80.84%; Δ 9.39% > 0%) |
| Interest Coverage Ratio: -65.67 > 6 (EBITDA TTM -189.9m / Interest Expense TTM 3.21m) |
Altman Z'' -11.65
| A: 0.20 (Total Current Assets 587.4m - Total Current Liabilities 420.9m) / Total Assets 840.4m |
| B: -2.45 (Retained Earnings -2.06b / Total Assets 840.4m) |
| C: -0.25 (EBIT TTM -210.6m / Avg Total Assets 857.3m) |
| D: -3.16 (Book Value of Equity -2.06b / Total Liabilities 652.1m) |
| Altman-Z'' Score: -11.65 = D |
Beneish M -3.33
| DSRI: 0.99 (Receivables 72.3m/66.9m, Revenue 773.6m/706.7m) |
| GMI: 1.00 (GM 89.48% / 89.39%) |
| AQI: 1.01 (AQ_t 0.03 / AQ_t-1 0.03) |
| SGI: 1.09 (Revenue 773.6m / 706.7m) |
| TATA: -0.35 (NI -219.1m - CFO 78.6m) / TA 840.4m) |
| Beneish M-Score: -3.33 (Cap -4..+1) = AA |
What is the price of ASAN shares?
As of February 07, 2026, the stock is trading at USD 8.76 with a total of 5,048,473 shares traded.
Over the past week, the price has changed by -14.54%, over one month by -33.08%, over three months by -33.13% and over the past year by -59.72%.
Over the past week, the price has changed by -14.54%, over one month by -33.08%, over three months by -33.13% and over the past year by -59.72%.
Is ASAN a buy, sell or hold?
Asana has received a consensus analysts rating of 3.21.
Therefor, it is recommend to hold ASAN.
- StrongBuy: 2
- Buy: 3
- Hold: 11
- Sell: 3
- StrongSell: 0
What are the forecasts/targets for the ASAN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.9 | 81.7% |
| Analysts Target Price | 15.9 | 81.7% |
| ValueRay Target Price | 7.2 | -18.2% |
ASAN Fundamental Data Overview February 02, 2026
P/E Forward = 28.169
P/S = 3.1416
P/B = 13.1036
Revenue TTM = 773.6m USD
EBIT TTM = -210.6m USD
EBITDA TTM = -189.9m USD
Long Term Debt = 35.6m USD (from longTermDebt, last quarter)
Short Term Debt = 30.0m USD (from shortTermDebt, last quarter)
Debt = 255.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 71.3m USD (from netDebt column, last quarter)
Enterprise Value = 2.22b USD (2.43b + Debt 255.2m - CCE 464.0m)
Interest Coverage Ratio = -65.67 (Ebit TTM -210.6m / Interest Expense TTM 3.21m)
EV/FCF = 30.69x (Enterprise Value 2.22b / FCF TTM 72.4m)
FCF Yield = 3.26% (FCF TTM 72.4m / Enterprise Value 2.22b)
FCF Margin = 9.36% (FCF TTM 72.4m / Revenue TTM 773.6m)
Net Margin = -28.32% (Net Income TTM -219.1m / Revenue TTM 773.6m)
Gross Margin = 89.48% ((Revenue TTM 773.6m - Cost of Revenue TTM 81.4m) / Revenue TTM)
Gross Margin QoQ = 88.90% (prev 89.73%)
Tobins Q-Ratio = 2.64 (Enterprise Value 2.22b / Total Assets 840.4m)
Interest Expense / Debt = 0.30% (Interest Expense 767.0k / Debt 255.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = -166.4m (EBIT -210.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.40 (Total Current Assets 587.4m / Total Current Liabilities 420.9m)
Debt / Equity = 1.35 (Debt 255.2m / totalStockholderEquity, last quarter 188.4m)
Debt / EBITDA = -0.38 (negative EBITDA) (Net Debt 71.3m / EBITDA -189.9m)
Debt / FCF = 0.99 (Net Debt 71.3m / FCF TTM 72.4m)
Total Stockholder Equity = 219.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -25.56% (Net Income -219.1m / Total Assets 840.4m)
RoE = -99.97% (Net Income TTM -219.1m / Total Stockholder Equity 219.2m)
RoCE = -82.67% (EBIT -210.6m / Capital Employed (Equity 219.2m + L.T.Debt 35.6m))
RoIC = -64.84% (negative operating profit) (NOPAT -166.4m / Invested Capital 256.6m)
WACC = 11.10% (E(2.43b)/V(2.69b) * Re(12.24%) + D(255.2m)/V(2.69b) * Rd(0.30%) * (1-Tc(0.21)))
Discount Rate = 12.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.55%
[DCF Debug] Terminal Value 57.69% ; FCFF base≈72.4m ; Y1≈47.5m ; Y5≈21.7m
Fair Price DCF = 1.32 (EV 278.7m - Net Debt 71.3m = Equity 207.3m / Shares 157.5m; r=11.10% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 60.89 | EPS CAGR: 70.42% | SUE: -0.67 | # QB: 0
Revenue Correlation: 95.95 | Revenue CAGR: 16.90% | SUE: 1.75 | # QB: 3
EPS next Quarter (2026-04-30): EPS=0.07 | Chg30d=+0.001 | Revisions Net=+0 | Analysts=11
EPS next Year (2027-01-31): EPS=0.36 | Chg30d=-0.004 | Revisions Net=+8 | Growth EPS=+38.8% | Growth Revenue=+8.5%
P/S = 3.1416
P/B = 13.1036
Revenue TTM = 773.6m USD
EBIT TTM = -210.6m USD
EBITDA TTM = -189.9m USD
Long Term Debt = 35.6m USD (from longTermDebt, last quarter)
Short Term Debt = 30.0m USD (from shortTermDebt, last quarter)
Debt = 255.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 71.3m USD (from netDebt column, last quarter)
Enterprise Value = 2.22b USD (2.43b + Debt 255.2m - CCE 464.0m)
Interest Coverage Ratio = -65.67 (Ebit TTM -210.6m / Interest Expense TTM 3.21m)
EV/FCF = 30.69x (Enterprise Value 2.22b / FCF TTM 72.4m)
FCF Yield = 3.26% (FCF TTM 72.4m / Enterprise Value 2.22b)
FCF Margin = 9.36% (FCF TTM 72.4m / Revenue TTM 773.6m)
Net Margin = -28.32% (Net Income TTM -219.1m / Revenue TTM 773.6m)
Gross Margin = 89.48% ((Revenue TTM 773.6m - Cost of Revenue TTM 81.4m) / Revenue TTM)
Gross Margin QoQ = 88.90% (prev 89.73%)
Tobins Q-Ratio = 2.64 (Enterprise Value 2.22b / Total Assets 840.4m)
Interest Expense / Debt = 0.30% (Interest Expense 767.0k / Debt 255.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = -166.4m (EBIT -210.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.40 (Total Current Assets 587.4m / Total Current Liabilities 420.9m)
Debt / Equity = 1.35 (Debt 255.2m / totalStockholderEquity, last quarter 188.4m)
Debt / EBITDA = -0.38 (negative EBITDA) (Net Debt 71.3m / EBITDA -189.9m)
Debt / FCF = 0.99 (Net Debt 71.3m / FCF TTM 72.4m)
Total Stockholder Equity = 219.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -25.56% (Net Income -219.1m / Total Assets 840.4m)
RoE = -99.97% (Net Income TTM -219.1m / Total Stockholder Equity 219.2m)
RoCE = -82.67% (EBIT -210.6m / Capital Employed (Equity 219.2m + L.T.Debt 35.6m))
RoIC = -64.84% (negative operating profit) (NOPAT -166.4m / Invested Capital 256.6m)
WACC = 11.10% (E(2.43b)/V(2.69b) * Re(12.24%) + D(255.2m)/V(2.69b) * Rd(0.30%) * (1-Tc(0.21)))
Discount Rate = 12.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.55%
[DCF Debug] Terminal Value 57.69% ; FCFF base≈72.4m ; Y1≈47.5m ; Y5≈21.7m
Fair Price DCF = 1.32 (EV 278.7m - Net Debt 71.3m = Equity 207.3m / Shares 157.5m; r=11.10% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 60.89 | EPS CAGR: 70.42% | SUE: -0.67 | # QB: 0
Revenue Correlation: 95.95 | Revenue CAGR: 16.90% | SUE: 1.75 | # QB: 3
EPS next Quarter (2026-04-30): EPS=0.07 | Chg30d=+0.001 | Revisions Net=+0 | Analysts=11
EPS next Year (2027-01-31): EPS=0.36 | Chg30d=-0.004 | Revisions Net=+8 | Growth EPS=+38.8% | Growth Revenue=+8.5%